Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphedema 1 Breast Neoplasms 1

Interventions

Fulvestrant 125 Trastuzumab 114 Paclitaxel 113 Letrozole 108 pembrolizumab 79 pertuzumab 75 palbociclib 75 Capecitabine 72 Anastrozole 72 Cyclophosphamide 70 Carboplatin 67 abemaciclib 64 exemestane 63 Tamoxifen 63 ribociclib 60 trastuzumab deruxtecan 57 Surveys and Questionnaires 51 Specimen Handling 50 Radiotherapy 49 Docetaxel 49 Magnetic Resonance Spectroscopy 48 Blood Specimen Collection 40 olaparib 39 Standard of Care 36 Biopsy 33 sacituzumab govitecan 31 130-nm albumin-bound paclitaxel 31 Doxorubicin 30 Exercise 29 eribulin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Body Mass Index × 1 year × Clear all

NCT02743858 2026-05-07

Lymphedema Surveillance Study

Memorial Sloan Kettering Cancer Center

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡